nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A4—Crohn's disease	0.523	0.571	CbGaD
Ipratropium bromide—SLC22A5—Crohn's disease	0.393	0.429	CbGaD
Ipratropium bromide—Breast feeding—Mesalazine—Crohn's disease	0.00185	0.0403	CcSEcCtD
Ipratropium bromide—Ulcer—Mercaptopurine—Crohn's disease	0.00126	0.0274	CcSEcCtD
Ipratropium bromide—Local reaction—Mesalazine—Crohn's disease	0.00117	0.0254	CcSEcCtD
Ipratropium bromide—Tongue oedema—Mesalazine—Crohn's disease	0.00115	0.0251	CcSEcCtD
Ipratropium bromide—Intestinal obstruction—Mesalazine—Crohn's disease	0.000946	0.0206	CcSEcCtD
Ipratropium bromide—Lung disorder—Mesalazine—Crohn's disease	0.000911	0.0199	CcSEcCtD
Ipratropium bromide—Tongue disorder—Mesalazine—Crohn's disease	0.000887	0.0194	CcSEcCtD
Ipratropium bromide—Intraocular pressure increased—Prednisone—Crohn's disease	0.000776	0.0169	CcSEcCtD
Ipratropium bromide—Stomatitis—Mercaptopurine—Crohn's disease	0.000648	0.0141	CcSEcCtD
Ipratropium bromide—Influenza like illness—Mesalazine—Crohn's disease	0.000626	0.0137	CcSEcCtD
Ipratropium bromide—Immune system disorder—Mercaptopurine—Crohn's disease	0.000539	0.0118	CcSEcCtD
Ipratropium bromide—Eye pain—Mesalazine—Crohn's disease	0.000519	0.0113	CcSEcCtD
Ipratropium bromide—Atrial fibrillation—Mesalazine—Crohn's disease	0.000494	0.0108	CcSEcCtD
Ipratropium bromide—Thirst—Mesalazine—Crohn's disease	0.000492	0.0107	CcSEcCtD
Ipratropium bromide—Arthritis—Mesalazine—Crohn's disease	0.000482	0.0105	CcSEcCtD
Ipratropium bromide—Glaucoma—Prednisone—Crohn's disease	0.000453	0.00989	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000439	0.00958	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Azathioprine—Crohn's disease	0.000426	0.00929	CcSEcCtD
Ipratropium bromide—Oedema—Mercaptopurine—Crohn's disease	0.000424	0.00925	CcSEcCtD
Ipratropium bromide—Skin disorder—Mercaptopurine—Crohn's disease	0.000412	0.00899	CcSEcCtD
Ipratropium bromide—Dysphagia—Mesalazine—Crohn's disease	0.000405	0.00883	CcSEcCtD
Ipratropium bromide—Influenza—Mesalazine—Crohn's disease	0.000405	0.00883	CcSEcCtD
Ipratropium bromide—Asthma—Mesalazine—Crohn's disease	0.000405	0.00883	CcSEcCtD
Ipratropium bromide—Bronchospasm—Mesalazine—Crohn's disease	0.000398	0.00869	CcSEcCtD
Ipratropium bromide—Bronchitis—Mesalazine—Crohn's disease	0.000389	0.00849	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Mesalazine—Crohn's disease	0.000388	0.00847	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000386	0.00843	CcSEcCtD
Ipratropium bromide—Dysuria—Mesalazine—Crohn's disease	0.000378	0.00826	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000376	0.00821	CcSEcCtD
Ipratropium bromide—Pollakiuria—Mesalazine—Crohn's disease	0.000374	0.00816	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000366	0.00799	CcSEcCtD
Ipratropium bromide—Ulcer—Prednisone—Crohn's disease	0.000361	0.00787	CcSEcCtD
Ipratropium bromide—Haemoglobin—Azathioprine—Crohn's disease	0.000357	0.0078	CcSEcCtD
Ipratropium bromide—Haemorrhage—Azathioprine—Crohn's disease	0.000356	0.00776	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000354	0.00772	CcSEcCtD
Ipratropium bromide—Stomatitis—Mesalazine—Crohn's disease	0.000352	0.00767	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Mesalazine—Crohn's disease	0.000351	0.00765	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Mesalazine—Crohn's disease	0.000351	0.00765	CcSEcCtD
Ipratropium bromide—Sweating—Mesalazine—Crohn's disease	0.000346	0.00755	CcSEcCtD
Ipratropium bromide—Epistaxis—Mesalazine—Crohn's disease	0.00034	0.00743	CcSEcCtD
Ipratropium bromide—Sinusitis—Mesalazine—Crohn's disease	0.000339	0.00739	CcSEcCtD
Ipratropium bromide—Haemoglobin—Mesalazine—Crohn's disease	0.000326	0.0071	CcSEcCtD
Ipratropium bromide—Rhinitis—Mesalazine—Crohn's disease	0.000325	0.00709	CcSEcCtD
Ipratropium bromide—Haemorrhage—Mesalazine—Crohn's disease	0.000324	0.00707	CcSEcCtD
Ipratropium bromide—Pharyngitis—Mesalazine—Crohn's disease	0.000322	0.00701	CcSEcCtD
Ipratropium bromide—Immune system disorder—Azathioprine—Crohn's disease	0.000321	0.00701	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Azathioprine—Crohn's disease	0.000321	0.00699	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Mesalazine—Crohn's disease	0.00032	0.00698	CcSEcCtD
Ipratropium bromide—Urethral disorder—Mesalazine—Crohn's disease	0.000318	0.00693	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000312	0.00682	CcSEcCtD
Ipratropium bromide—Eye disorder—Mesalazine—Crohn's disease	0.000303	0.00661	CcSEcCtD
Ipratropium bromide—Tinnitus—Mesalazine—Crohn's disease	0.000302	0.00659	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Mesalazine—Crohn's disease	0.000301	0.00656	CcSEcCtD
Ipratropium bromide—Immune system disorder—Mesalazine—Crohn's disease	0.000293	0.00638	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Mesalazine—Crohn's disease	0.000292	0.00637	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00029	0.00633	CcSEcCtD
Ipratropium bromide—Flatulence—Mesalazine—Crohn's disease	0.000278	0.00606	CcSEcCtD
Ipratropium bromide—Tension—Mesalazine—Crohn's disease	0.000277	0.00604	CcSEcCtD
Ipratropium bromide—Dysgeusia—Mesalazine—Crohn's disease	0.000276	0.00603	CcSEcCtD
Ipratropium bromide—Nervousness—Mesalazine—Crohn's disease	0.000274	0.00598	CcSEcCtD
Ipratropium bromide—Back pain—Mesalazine—Crohn's disease	0.000273	0.00595	CcSEcCtD
Ipratropium bromide—Vomiting—Mercaptopurine—Crohn's disease	0.00027	0.00588	CcSEcCtD
Ipratropium bromide—Rash—Mercaptopurine—Crohn's disease	0.000267	0.00583	CcSEcCtD
Ipratropium bromide—Dermatitis—Mercaptopurine—Crohn's disease	0.000267	0.00583	CcSEcCtD
Ipratropium bromide—Vision blurred—Mesalazine—Crohn's disease	0.000266	0.0058	CcSEcCtD
Ipratropium bromide—Tremor—Mesalazine—Crohn's disease	0.000264	0.00576	CcSEcCtD
Ipratropium bromide—Myalgia—Azathioprine—Crohn's disease	0.000264	0.00575	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000262	0.00571	CcSEcCtD
Ipratropium bromide—Angioedema—Mesalazine—Crohn's disease	0.000258	0.00562	CcSEcCtD
Ipratropium bromide—Nausea—Mercaptopurine—Crohn's disease	0.000252	0.0055	CcSEcCtD
Ipratropium bromide—Infection—Azathioprine—Crohn's disease	0.000251	0.00548	CcSEcCtD
Ipratropium bromide—Palpitations—Mesalazine—Crohn's disease	0.000249	0.00544	CcSEcCtD
Ipratropium bromide—Cough—Mesalazine—Crohn's disease	0.000246	0.00537	CcSEcCtD
Ipratropium bromide—Skin disorder—Azathioprine—Crohn's disease	0.000245	0.00535	CcSEcCtD
Ipratropium bromide—Hypertension—Mesalazine—Crohn's disease	0.000243	0.00531	CcSEcCtD
Ipratropium bromide—Chest pain—Mesalazine—Crohn's disease	0.00024	0.00524	CcSEcCtD
Ipratropium bromide—Myalgia—Mesalazine—Crohn's disease	0.00024	0.00524	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000238	0.0052	CcSEcCtD
Ipratropium bromide—Hypotension—Azathioprine—Crohn's disease	0.000236	0.00515	CcSEcCtD
Ipratropium bromide—Dry mouth—Mesalazine—Crohn's disease	0.000235	0.00512	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00023	0.00502	CcSEcCtD
Ipratropium bromide—Oedema—Mesalazine—Crohn's disease	0.00023	0.00502	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Mesalazine—Crohn's disease	0.00023	0.00502	CcSEcCtD
Ipratropium bromide—Infection—Mesalazine—Crohn's disease	0.000229	0.00499	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Mesalazine—Crohn's disease	0.000226	0.00492	CcSEcCtD
Ipratropium bromide—Tachycardia—Mesalazine—Crohn's disease	0.000225	0.0049	CcSEcCtD
Ipratropium bromide—Skin disorder—Mesalazine—Crohn's disease	0.000224	0.00488	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000222	0.00485	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000218	0.00476	CcSEcCtD
Ipratropium bromide—Hypotension—Mesalazine—Crohn's disease	0.000215	0.00469	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00021	0.00457	CcSEcCtD
Ipratropium bromide—Insomnia—Mesalazine—Crohn's disease	0.000208	0.00454	CcSEcCtD
Ipratropium bromide—Paraesthesia—Mesalazine—Crohn's disease	0.000207	0.00451	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000207	0.00451	CcSEcCtD
Ipratropium bromide—Dyspnoea—Mesalazine—Crohn's disease	0.000205	0.00448	CcSEcCtD
Ipratropium bromide—Somnolence—Mesalazine—Crohn's disease	0.000205	0.00446	CcSEcCtD
Ipratropium bromide—Dyspepsia—Mesalazine—Crohn's disease	0.000203	0.00442	CcSEcCtD
Ipratropium bromide—Abdominal pain—Azathioprine—Crohn's disease	0.0002	0.00436	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000199	0.00434	CcSEcCtD
Ipratropium bromide—Fatigue—Mesalazine—Crohn's disease	0.000198	0.00433	CcSEcCtD
Ipratropium bromide—Pain—Mesalazine—Crohn's disease	0.000197	0.00429	CcSEcCtD
Ipratropium bromide—Constipation—Mesalazine—Crohn's disease	0.000197	0.00429	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000188	0.00411	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Prednisone—Crohn's disease	0.000187	0.00408	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Azathioprine—Crohn's disease	0.000186	0.00406	CcSEcCtD
Ipratropium bromide—Urticaria—Mesalazine—Crohn's disease	0.000183	0.00399	CcSEcCtD
Ipratropium bromide—Abdominal pain—Mesalazine—Crohn's disease	0.000182	0.00397	CcSEcCtD
Ipratropium bromide—Diarrhoea—Azathioprine—Crohn's disease	0.000173	0.00377	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisone—Crohn's disease	0.000172	0.00376	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisone—Crohn's disease	0.000171	0.00374	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Mesalazine—Crohn's disease	0.00017	0.0037	CcSEcCtD
Ipratropium bromide—Dizziness—Azathioprine—Crohn's disease	0.000167	0.00365	CcSEcCtD
Ipratropium bromide—Asthenia—Mesalazine—Crohn's disease	0.000165	0.0036	CcSEcCtD
Ipratropium bromide—Pruritus—Mesalazine—Crohn's disease	0.000163	0.00355	CcSEcCtD
Ipratropium bromide—Vomiting—Azathioprine—Crohn's disease	0.000161	0.00351	CcSEcCtD
Ipratropium bromide—Eye disorder—Prednisone—Crohn's disease	0.00016	0.00349	CcSEcCtD
Ipratropium bromide—Rash—Azathioprine—Crohn's disease	0.000159	0.00348	CcSEcCtD
Ipratropium bromide—Dermatitis—Azathioprine—Crohn's disease	0.000159	0.00347	CcSEcCtD
Ipratropium bromide—Flushing—Prednisone—Crohn's disease	0.000159	0.00347	CcSEcCtD
Ipratropium bromide—Headache—Azathioprine—Crohn's disease	0.000158	0.00345	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mesalazine—Crohn's disease	0.000157	0.00344	CcSEcCtD
Ipratropium bromide—Immune system disorder—Prednisone—Crohn's disease	0.000155	0.00338	CcSEcCtD
Ipratropium bromide—Dizziness—Mesalazine—Crohn's disease	0.000152	0.00332	CcSEcCtD
Ipratropium bromide—Nausea—Azathioprine—Crohn's disease	0.00015	0.00327	CcSEcCtD
Ipratropium bromide—Vomiting—Mesalazine—Crohn's disease	0.000146	0.00319	CcSEcCtD
Ipratropium bromide—Rash—Mesalazine—Crohn's disease	0.000145	0.00317	CcSEcCtD
Ipratropium bromide—Dermatitis—Mesalazine—Crohn's disease	0.000145	0.00316	CcSEcCtD
Ipratropium bromide—Headache—Mesalazine—Crohn's disease	0.000144	0.00315	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisone—Crohn's disease	0.000141	0.00307	CcSEcCtD
Ipratropium bromide—Nausea—Mesalazine—Crohn's disease	0.000137	0.00298	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisone—Crohn's disease	0.000136	0.00297	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisone—Crohn's disease	0.000129	0.00281	CcSEcCtD
Ipratropium bromide—Myalgia—Prednisone—Crohn's disease	0.000127	0.00277	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000126	0.00275	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisone—Crohn's disease	0.000122	0.00266	CcSEcCtD
Ipratropium bromide—Oedema—Prednisone—Crohn's disease	0.000122	0.00266	CcSEcCtD
Ipratropium bromide—Infection—Prednisone—Crohn's disease	0.000121	0.00264	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Prednisone—Crohn's disease	0.000119	0.00261	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisone—Crohn's disease	0.000119	0.00259	CcSEcCtD
Ipratropium bromide—Skin disorder—Prednisone—Crohn's disease	0.000118	0.00258	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisone—Crohn's disease	0.000118	0.00257	CcSEcCtD
Ipratropium bromide—CHRM3—muscle of abdomen—Crohn's disease	0.000114	0.473	CbGeAlD
Ipratropium bromide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000111	0.00242	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisone—Crohn's disease	0.00011	0.0024	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisone—Crohn's disease	0.000109	0.00239	CcSEcCtD
Ipratropium bromide—Dyspepsia—Prednisone—Crohn's disease	0.000107	0.00234	CcSEcCtD
Ipratropium bromide—Fatigue—Prednisone—Crohn's disease	0.000105	0.00229	CcSEcCtD
Ipratropium bromide—Constipation—Prednisone—Crohn's disease	0.000104	0.00227	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Prednisone—Crohn's disease	9.96e-05	0.00217	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisone—Crohn's disease	9.67e-05	0.00211	CcSEcCtD
Ipratropium bromide—Abdominal pain—Prednisone—Crohn's disease	9.63e-05	0.0021	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisone—Crohn's disease	8.97e-05	0.00196	CcSEcCtD
Ipratropium bromide—Asthenia—Prednisone—Crohn's disease	8.74e-05	0.00191	CcSEcCtD
Ipratropium bromide—Pruritus—Prednisone—Crohn's disease	8.62e-05	0.00188	CcSEcCtD
Ipratropium bromide—Diarrhoea—Prednisone—Crohn's disease	8.33e-05	0.00182	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisone—Crohn's disease	8.05e-05	0.00176	CcSEcCtD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—RASGRP1—Crohn's disease	7.76e-05	0.00206	CbGpPWpGaD
Ipratropium bromide—Vomiting—Prednisone—Crohn's disease	7.74e-05	0.00169	CcSEcCtD
Ipratropium bromide—CHRM5—GPCR ligand binding—CCR6—Crohn's disease	7.68e-05	0.00204	CbGpPWpGaD
Ipratropium bromide—Rash—Prednisone—Crohn's disease	7.68e-05	0.00168	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisone—Crohn's disease	7.67e-05	0.00167	CcSEcCtD
Ipratropium bromide—SLC22A4—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.66e-05	0.00204	CbGpPWpGaD
Ipratropium bromide—Headache—Prednisone—Crohn's disease	7.63e-05	0.00166	CcSEcCtD
Ipratropium bromide—CHRM1—GPCR ligand binding—GPR65—Crohn's disease	7.59e-05	0.00202	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—GPR65—Crohn's disease	7.57e-05	0.00201	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—GPR65—Crohn's disease	7.49e-05	0.00199	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.3e-05	0.00194	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.28e-05	0.00193	CbGpPWpGaD
Ipratropium bromide—Nausea—Prednisone—Crohn's disease	7.23e-05	0.00158	CcSEcCtD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL10—Crohn's disease	7.21e-05	0.00192	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	7.21e-05	0.00191	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	7.1e-05	0.00189	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	7.08e-05	0.00188	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	7.01e-05	0.00186	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	6.96e-05	0.00185	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	6.94e-05	0.00184	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—PTGER4—Crohn's disease	6.76e-05	0.0018	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—MLN—Crohn's disease	6.66e-05	0.00177	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—MLN—Crohn's disease	6.64e-05	0.00176	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—MLN—Crohn's disease	6.57e-05	0.00175	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CCR9—Crohn's disease	6.55e-05	0.00174	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ACKR2—Crohn's disease	6.38e-05	0.00169	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ACKR2—Crohn's disease	6.36e-05	0.00169	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ACKR2—Crohn's disease	6.3e-05	0.00167	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.25e-05	0.00166	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.23e-05	0.00166	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	6.17e-05	0.00164	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—GPR65—Crohn's disease	6.09e-05	0.00162	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—MLN—Crohn's disease	6.05e-05	0.00161	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—MLN—Crohn's disease	6.03e-05	0.0016	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—MLN—Crohn's disease	5.97e-05	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CCR9—Crohn's disease	5.95e-05	0.00158	CbGpPWpGaD
Ipratropium bromide—SLC22A5—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.76e-05	0.00153	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—GPR65—Crohn's disease	5.53e-05	0.00147	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	5.45e-05	0.00145	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	5.41e-05	0.00144	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	5.39e-05	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ACKR2—Crohn's disease	5.35e-05	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	5.34e-05	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MLN—Crohn's disease	5.07e-05	0.00135	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.04e-05	0.00134	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.81e-05	0.00128	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	4.76e-05	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	4.75e-05	0.00126	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	4.7e-05	0.00125	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	4.64e-05	0.00123	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	4.62e-05	0.00123	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	4.6e-05	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	4.56e-05	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	4.34e-05	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	4.29e-05	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	4.28e-05	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	4.24e-05	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	4.19e-05	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	4.18e-05	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	4.14e-05	0.0011	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	4.06e-05	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.94e-05	0.00105	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	3.94e-05	0.00105	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	3.9e-05	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PLA2G4F—Crohn's disease	3.89e-05	0.00103	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—ALB—Crohn's disease	3.89e-05	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	3.88e-05	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	3.85e-05	0.00102	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	3.84e-05	0.00102	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	3.82e-05	0.00102	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.78e-05	0.00101	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	3.77e-05	0.001	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	3.76e-05	0.000998	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	3.72e-05	0.000988	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MLN—Crohn's disease	3.57e-05	0.000949	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MLN—Crohn's disease	3.56e-05	0.000946	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.55e-05	0.000943	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	3.54e-05	0.00094	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MLN—Crohn's disease	3.53e-05	0.000937	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCR9—Crohn's disease	3.52e-05	0.000934	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	3.47e-05	0.000922	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	3.39e-05	0.0009	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	3.38e-05	0.000897	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTMR3—Crohn's disease	3.31e-05	0.00088	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—GPR65—Crohn's disease	3.27e-05	0.000868	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	3.27e-05	0.000868	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	3.26e-05	0.000865	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	3.26e-05	0.000865	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.25e-05	0.000864	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	3.22e-05	0.000857	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	3.15e-05	0.000837	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	3.06e-05	0.000812	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	3.05e-05	0.00081	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	3.02e-05	0.000802	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL3—Crohn's disease	2.96e-05	0.000785	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—ALB—Crohn's disease	2.93e-05	0.000777	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	2.86e-05	0.00076	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	2.86e-05	0.000759	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	2.85e-05	0.000756	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	2.84e-05	0.000755	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	2.82e-05	0.000749	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	2.78e-05	0.000737	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	2.77e-05	0.000735	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.75e-05	0.000729	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	2.74e-05	0.000728	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	2.71e-05	0.000719	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	2.7e-05	0.000717	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	2.69e-05	0.000715	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	2.68e-05	0.000713	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	2.67e-05	0.00071	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	2.66e-05	0.000706	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—FADS1—Crohn's disease	2.58e-05	0.000685	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	2.48e-05	0.000658	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR9—Crohn's disease	2.48e-05	0.000658	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR9—Crohn's disease	2.47e-05	0.000656	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.47e-05	0.000655	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	2.44e-05	0.000649	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR9—Crohn's disease	2.44e-05	0.000649	CbGpPWpGaD
Ipratropium bromide—CHRM5—epithelium—Crohn's disease	2.44e-05	0.101	CbGeAlD
Ipratropium bromide—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	2.44e-05	0.000647	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GPX4—Crohn's disease	2.42e-05	0.000642	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	2.41e-05	0.000641	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GCKR—Crohn's disease	2.33e-05	0.00062	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCR6—Crohn's disease	2.33e-05	0.000619	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	2.33e-05	0.000619	CbGpPWpGaD
Ipratropium bromide—CHRM5—skin of body—Crohn's disease	2.32e-05	0.0958	CbGeAlD
Ipratropium bromide—CHRM1—Signaling Pathways—GPR65—Crohn's disease	2.3e-05	0.000611	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GPR65—Crohn's disease	2.29e-05	0.000609	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	2.29e-05	0.000609	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.29e-05	0.000608	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	2.29e-05	0.000607	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.28e-05	0.000606	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	2.28e-05	0.000606	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GPR65—Crohn's disease	2.27e-05	0.000604	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	2.26e-05	0.000601	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.26e-05	0.0006	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	2.22e-05	0.000589	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	2.22e-05	0.000589	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	2.21e-05	0.000587	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	2.19e-05	0.000581	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RBX1—Crohn's disease	2.11e-05	0.00056	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL3—Crohn's disease	2.08e-05	0.000553	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL3—Crohn's disease	2.08e-05	0.000551	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	2.07e-05	0.00055	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL3—Crohn's disease	2.06e-05	0.000546	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	2.05e-05	0.000545	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	2.01e-05	0.000535	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	2.01e-05	0.000533	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	1.99e-05	0.000528	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTMR3—Crohn's disease	1.98e-05	0.000526	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	1.85e-05	0.000491	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	1.83e-05	0.000487	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	1.79e-05	0.000476	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL3—Crohn's disease	1.75e-05	0.000464	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	1.74e-05	0.000463	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	1.74e-05	0.000462	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.74e-05	0.000461	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	1.73e-05	0.00046	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	1.72e-05	0.000457	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	1.69e-05	0.000449	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR6—Crohn's disease	1.64e-05	0.000436	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR6—Crohn's disease	1.63e-05	0.000434	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR6—Crohn's disease	1.62e-05	0.00043	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	1.61e-05	0.000427	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	1.6e-05	0.000425	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	1.59e-05	0.000421	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—FADS1—Crohn's disease	1.54e-05	0.00041	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	1.53e-05	0.000407	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	1.53e-05	0.000407	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.52e-05	0.000404	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RBX1—Crohn's disease	1.48e-05	0.000394	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RBX1—Crohn's disease	1.48e-05	0.000393	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RBX1—Crohn's disease	1.46e-05	0.000389	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	1.46e-05	0.000388	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	1.46e-05	0.000387	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	1.45e-05	0.000386	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX4—Crohn's disease	1.44e-05	0.000384	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	1.44e-05	0.000384	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	1.44e-05	0.000382	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	1.44e-05	0.000382	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	1.43e-05	0.000379	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	1.4e-05	0.000372	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GCKR—Crohn's disease	1.4e-05	0.000371	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	1.39e-05	0.00037	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	1.32e-05	0.000351	CbGpPWpGaD
Ipratropium bromide—CHRM3—smooth muscle tissue—Crohn's disease	1.31e-05	0.0543	CbGeAlD
Ipratropium bromide—SLC22A4—digestive system—Crohn's disease	1.31e-05	0.0543	CbGeAlD
Ipratropium bromide—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	1.3e-05	0.000345	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	1.3e-05	0.000344	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.29e-05	0.000344	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	1.28e-05	0.000341	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	1.27e-05	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	1.26e-05	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	1.26e-05	0.000334	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	1.24e-05	0.000331	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL3—Crohn's disease	1.23e-05	0.000327	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL3—Crohn's disease	1.23e-05	0.000326	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	1.22e-05	0.000325	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL3—Crohn's disease	1.21e-05	0.000322	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	1.19e-05	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	1.19e-05	0.000315	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	1.17e-05	0.000312	CbGpPWpGaD
Ipratropium bromide—SLC22A5—skin of body—Crohn's disease	1.09e-05	0.0449	CbGeAlD
Ipratropium bromide—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	1.08e-05	0.000287	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	1.08e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	1.08e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	1.07e-05	0.000285	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	1.07e-05	0.000283	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	1.06e-05	0.000283	CbGpPWpGaD
Ipratropium bromide—CHRM3—digestive system—Crohn's disease	1.04e-05	0.0429	CbGeAlD
Ipratropium bromide—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	1.03e-05	0.000273	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	1.02e-05	0.000272	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	1.01e-05	0.000269	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—FADS1—Crohn's disease	1.01e-05	0.000268	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	9.85e-06	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	9.82e-06	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	9.8e-06	0.00026	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	9.77e-06	0.00026	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	9.73e-06	0.000258	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	9.68e-06	0.000257	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX4—Crohn's disease	9.44e-06	0.000251	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	9.3e-06	0.000247	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	9.27e-06	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	9.18e-06	0.000244	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCKR—Crohn's disease	9.12e-06	0.000242	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	8.95e-06	0.000238	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	8.92e-06	0.000237	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	8.83e-06	0.000235	CbGpPWpGaD
Ipratropium bromide—SLC22A5—digestive system—Crohn's disease	8.69e-06	0.0359	CbGeAlD
Ipratropium bromide—CHRM5—Signaling Pathways—TYK2—Crohn's disease	8.62e-06	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	8.62e-06	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	8.59e-06	0.000228	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	8.5e-06	0.000226	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—JAK2—Crohn's disease	8.22e-06	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	7.51e-06	0.000199	CbGpPWpGaD
Ipratropium bromide—SLC22A4—lymph node—Crohn's disease	7.5e-06	0.031	CbGeAlD
Ipratropium bromide—CHRM3—Metabolism—ALB—Crohn's disease	7.43e-06	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—Crohn's disease	7.14e-06	0.00019	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—Crohn's disease	6.5e-06	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TYK2—Crohn's disease	6.07e-06	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TYK2—Crohn's disease	6.05e-06	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STAT3—Crohn's disease	6.04e-06	0.00016	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TYK2—Crohn's disease	5.99e-06	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JAK2—Crohn's disease	5.79e-06	0.000154	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JAK2—Crohn's disease	5.77e-06	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JAK2—Crohn's disease	5.72e-06	0.000152	CbGpPWpGaD
Ipratropium bromide—CYP3A4—digestive system—Crohn's disease	5.7e-06	0.0236	CbGeAlD
Ipratropium bromide—CYP2D6—digestive system—Crohn's disease	5.61e-06	0.0232	CbGeAlD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	5.29e-06	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	5.27e-06	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	5.22e-06	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—Crohn's disease	5.03e-06	0.000133	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—Crohn's disease	5.01e-06	0.000133	CbGpPWpGaD
Ipratropium bromide—SLC22A5—lymph node—Crohn's disease	4.96e-06	0.0205	CbGeAlD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—Crohn's disease	4.96e-06	0.000132	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—Crohn's disease	4.44e-06	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STAT3—Crohn's disease	4.25e-06	0.000113	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STAT3—Crohn's disease	4.24e-06	0.000113	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—Crohn's disease	4.22e-06	0.000112	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STAT3—Crohn's disease	4.2e-06	0.000111	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.88e-06	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—Crohn's disease	2.97e-06	7.89e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—Crohn's disease	2.96e-06	7.86e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—Crohn's disease	2.93e-06	7.78e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—Crohn's disease	2.9e-06	7.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.54e-06	6.75e-05	CbGpPWpGaD
